Center-Authored Papers

Filters: Author is Scholler, Nathalie  [Clear All Filters]
2011
Kalogera E, Scholler N, Powless C, Weaver A, Drapkin R, Li J, Jiang S-W, Podratz K, Urban ND, Dowdy SC.  2011.  Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.. Gynecologic oncology. 124(20):270-275. Abstract
Urban ND, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD et al..  2011.  Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer.. Journal of the National Cancer Institute. 103(21):1630-4. Abstract
Zhu CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban ND, Mor G, Bast RC, Moore LE et al..  2011.  A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
Cramer DW, Bast RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G et al..  2011.  Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.. Cancer prevention research (Philadelphia, Pa.). 4(3):365-74. Abstract
2010
Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban ND.  2010.  Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.. Gynecologic oncology. 116(3):378-83. Abstract
Anderson GL, McIntosh MW, Wu LL, Barnett M, Goodman GE, Thorpe JD, Bergan L, Thornquist MD, Scholler N, Kim N et al..  2010.  Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.. Journal of the National Cancer Institute. 102(1):26-38. Abstract
2009
Shah CA, Lowe KA, Paley P, Wallace E, Anderson GL, McIntosh MW, Andersen MR, Scholler N, Bergan LA, Thorpe JD et al..  2009.  Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1365-72. Abstract
Chen A, Kozak D, Battersby BJ, Forrest RM, Scholler N, Urban ND, Trau M.  2009.  Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.. Langmuir : the ACS journal of surfaces and colloids. 25(23):13510-5. Abstract
2008
Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh MW, Andersen MR, Scholler N, Bergan L, Thorpe J et al..  2008.  Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9):2480-7. Abstract
Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, Thorpe JD, Gross JA, Garvik BM, Drapkin R et al..  2008.  Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(9):2647-55. Abstract
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ et al..  2008.  A mouse to human search for plasma proteome changes associated with pancreatic tumor development.. PLoS medicine. 5(6):e123. Abstract
Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban ND.  2008.  Combining a symptoms index with CA 125 to improve detection of ovarian cancer.. Cancer. 113(3):484-9. Abstract
Palmer C, Duan X, Hawley S, Scholler N, Thorpe JD, Sahota RA, Wong MQ, Wray A, Bergan LA, Drescher CW et al..  2008.  Systematic evaluation of candidate blood markers for detecting ovarian cancer.. PloS one. 3(7):e2633. Abstract
Scholler N, Gross JA, Garvik B, Wells L, Liu Y, Loch CM, Ramirez AB, McIntosh MW, Lampe PD, Urban ND.  2008.  Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.. Journal of translational medicine. 6:41. Abstract